The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER2-negative early breast cancer.
 
Andrew Tutt
No Relationships to Disclose
 
Judy Ellen Garber
No Relationships to Disclose
 
Bella Kaufman
No Relationships to Disclose
 
Giuseppe Viale
No Relationships to Disclose
 
Debora Fumagalli
No Relationships to Disclose
 
Priya Rastogi
No Relationships to Disclose
 
Richard D. Gelber
No Relationships to Disclose
 
Evandro de Azambuja
No Relationships to Disclose
 
Anitra Fielding
No Relationships to Disclose
 
Judith Balmana Gelpi
No Relationships to Disclose
 
Karen A. Gelmon
No Relationships to Disclose
 
Nigel Baker
No Relationships to Disclose
 
Amal Arahmani
No Relationships to Disclose
 
Elzbieta Senkus-Konefka
No Relationships to Disclose
 
Eleanor Mc Fadden
No Relationships to Disclose
 
Vassiliki Karantza
No Relationships to Disclose
 
Sunil R. Lakhani
No Relationships to Disclose
 
Greg Yothers
No Relationships to Disclose
 
Christine Campbell
No Relationships to Disclose
 
Charles E. Geyer
No Relationships to Disclose